New NIH policies will require researchers to study male and female biology.
Will an antibody signature make for a new Alzheimer’s diagnostic?
Mesulam Awarded Potamkin Prize Three’s Company: Florbetaben Approved, Excludes AD Diagnosis PET Tracers Enlighten at Neurology Conference Blood Patterns: Prowling for Alzheimer’s Clues in Plasma Tau imaging of patients with different kinds of dementia and ...
By paring back calcium signaling, researchers prevented signs of Alzheimer’s in mice carrying a presenilin mutation. Could the strategy work in humans?
MetLife rewards research on secretases, toxic Aβ transmission.
New twist to fluorescence-based microscopy lets scientists see up-close how Aβ aggregates in living cells.
A candidate reference method for measuring Aβ42 in cerebrospinal fluid brings researchers closer to standardization.
Playing nursemaid, TGF-β helps new neurons in the brain survive, develop, and migrate.
In award-winning documentary, son traces his mother’s progression into Alzheimer’s disease.
Combination Drug Trials: Time to Open a New Front in AD? Combination Trials: FDA Puts Flesh on Bones of Draft Guidance Combination Trials: Companies Can Play Well in One Sandbox Building a Roadmap for Shared Combination Drug Trials ACT-AD FDA/AD Allies ...
Meeting Explores Regulatory Requirements for Parkinson's MCI Michael J. Fox Foundation Conference ...
The proportion of seniors with dementia in England appears to be on the decline, new research suggests.
Brain atrophy plagues more than just people with neurodegenerative disorders...
An ultra-high-resolution 3D map of the human brain promises to help scientists studying neuroanatomy, neurosurgery, neurodegenerative disease, and more.
Similar to Alzheimer's disease, PD dementia begins with subtle deficits in cognition that progress to symptoms recognizable as mild cognitive impairment.